{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T09:32:45Z","timestamp":1763458365610,"version":"build-2065373602"},"reference-count":65,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Background: This computational analysis investigated sequence complementarities between the TRIM33 gene and human noncoding (nc)RNAs and characterized their interactions in the context of paraneoplastic dermatomyositis. Methods: TRIM33 FASTA sequence (NCBI Reference Sequence: NC_000001.11) was used for BLASTN analysis against Human GRCh38 in the Ensembl.org database. Retrieved ncRNAs showing hits to TRIM33 were searched in the GeneCards.org database and further analyzed through RNAInter, QmRLFS-finder, Spliceator, and NcPath enrichment analysis. Results: A total of 100 hits were found, involving the lncRNAs NNT-AS1, MKLN1-AS, LINC01206, and PAXBP1-AS1, whose dysregulation has been reported in either cancer or dermatomyositis. Additionally, the lncRNAs NNT-AS1 and PAXBP1-AS1 may interact with microRNA-142-3p, reducing its expression and increasing that of TRIM33. Sequence complementarity affected only TRIM33 intron 1, possibly resulting in alternatively spliced isoforms of TIF1\u03b3 with increased immunogenicity. The results also revealed nucleotide alignment between TRIM33 and the gene regulatory elements of 28 ncRNA genes involved in immune pathways. Conclusions: This pivotal study demonstrates sequence complementarity between TRIM33 and human ncRNAs dysregulated in cancer and dermatomyositis. This scenario may lead to the overproduction of more immunogenic TIF1\u03b3 variants in tumors and the stimulation of autoimmunity. Further experimental analyses using targeted methods such as Western blot or Chip-Seq are required to confirm these data.<\/jats:p>","DOI":"10.3390\/jpm14060628","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T03:52:53Z","timestamp":1718337173000},"page":"628","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sequence Alignment between TRIM33 Gene and Human Noncoding RNAs: A Potential Explanation for Paraneoplastic Dermatomyositis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8426-1395","authenticated-orcid":false,"given":"Rossella","family":"Talotta","sequence":"first","affiliation":[{"name":"Rheumatology Unit, Department of Clinical and Experimental Medicine, University Hospital \u201cGaetano Martino\u201d, 98124 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.40320","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups","volume":"69","author":"Lundberg","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/art.42345","article-title":"Genetic Influences in Cancer-Associated Myositis","volume":"75","author":"Patasova","year":"2023","journal-title":"Arthritis Rheumatol."},{"key":"ref_3","first-page":"199","article-title":"Idiopathic Inflammatory Myopathies: One Year in Review 2022","volume":"41","author":"Dourado","year":"2023","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/cei.12194","article-title":"Diagnosis, Pathogenesis and Treatment of Myositis: Recent Advances","volume":"175","author":"Carstens","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fneur.2016.00064","article-title":"Idiopathic Inflammatory Myopathies: Clinical Approach and Management","volume":"7","author":"Malik","year":"2016","journal-title":"Front. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mayocp.2012.10.017","article-title":"Idiopathic Inflammatory Myopathies: Current Trends in Pathogenesis, Clinical Features, and Up-to-Date Treatment Recommendations","volume":"88","author":"Ernste","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory Muscle Diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1002\/art.38093","article-title":"Most Patients with Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1\u03b3","volume":"65","author":"Fiorentino","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaad.2014.12.009","article-title":"Distinctive Cutaneous and Systemic Features Associated with Antitranscriptional Intermediary Factor-1\u03b3 Antibodies in Adults with Dermatomyositis","volume":"72","author":"Fiorentino","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/25785826.2020.1791402","article-title":"Transcriptional Intermediary Factor 1 (TIF1) and Anti-TIF1\u03b3 Antibody-Positive Dermatomyositis","volume":"44","author":"Kotobuki","year":"2020","journal-title":"Immunol. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/rheumatology\/kez572","article-title":"Anti-TIF1-\u0393autoantibodies: Warning Lights of a Tumour Autoantigen","volume":"59","author":"Vulsteke","year":"2020","journal-title":"Rheumatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3389\/fonc.2019.00979","article-title":"The Roles of TIF1\u03b3 in Cancer","volume":"9","author":"Yu","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.stem.2011.02.005","article-title":"Adult Hematopoiesis Is Regulated by TIF1\u03b3, a Repressor of TAL1 and PU.1 Transcriptional Activity","volume":"8","author":"Kusy","year":"2011","journal-title":"Cell Stem Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.1093\/rheumatology\/keab260","article-title":"TRIM33 Gene Somatic Mutations Identified by next Generation Sequencing in Neoplasms of Patients with Anti-TIF1\u03b3positive Cancer-Associated Dermatomyositis","volume":"60","author":"Cordel","year":"2021","journal-title":"Rheumatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/rheumatology\/kex413","article-title":"Tumour TIF1 Mutations and Loss of Heterozygosity Related to Cancer-Associated Myositis","volume":"57","author":"Balada","year":"2018","journal-title":"Rheumatology"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/bs.ai.2019.09.003","article-title":"Molecular Mechanisms of T Helper 17 Cell Differentiation: Emerging Roles for Transcription Cofactors","volume":"144","author":"Jiang","year":"2019","journal-title":"Adv. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/1346-8138.15284","article-title":"Clinical Significance of Serum Levels of Anti-Transcriptional Intermediary Factor 1-\u03b3 Antibody in Patients with Dermatomyositis","volume":"47","author":"Ikeda","year":"2020","journal-title":"J. Dermatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1126\/science.aan2507","article-title":"A Pathology Atlas of the Human Cancer Transcriptome","volume":"357","author":"Uhlen","year":"2017","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.molcel.2021.03.028","article-title":"A Pan-Cancer Transcriptome Analysis of Exitron Splicing Identifies Novel Cancer Driver Genes and Neoepitopes","volume":"81","author":"Wang","year":"2021","journal-title":"Mol. Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcancer.2020.09.007","article-title":"Transcriptomics and Solid Tumors: The next Frontier in Precision Cancer Medicine","volume":"84","author":"Tsimberidou","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"32818","DOI":"10.1038\/srep32818","article-title":"Transcriptomic Profiling of Long Non-Coding RNAs in Dermatomyositis by Microarray Analysis","volume":"6","author":"Peng","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2217\/epi-2018-0064","article-title":"Integrated Comparison of the MiRNAome and MRNAome in Muscles of Dermatomyositis and Polymyositis Reveals Common and Specific MiRNA-MRNAs","volume":"11","author":"Gao","year":"2019","journal-title":"Epigenomics"},{"key":"ref_23","first-page":"D682","article-title":"Ensembl 2020","volume":"48","author":"Yates","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_24","first-page":"1.30.1","article-title":"The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses","volume":"2016","author":"Stelzer","year":"2016","journal-title":"Curr. Protoc. Bioinform."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The Mutational Constraint Spectrum Quantified from Variation in 141,456 Humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"D189","DOI":"10.1093\/nar\/gkz804","article-title":"RNAInter in 2020: RNA Interactome Repository with Increased Coverage and Annotation","volume":"48","author":"Lin","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"W527","DOI":"10.1093\/nar\/gkv344","article-title":"QmRLFS-Finder: A Model, Web Server and Stand-Alone Tool for Prediction and Analysis of R-Loop Forming Sequences: Table 1","volume":"43","author":"Jenjaroenpun","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Scalzitti, N., Kress, A., Orhand, R., Weber, T., Moulinier, L., Jeannin-Girardon, A., Collet, P., Poch, O., and Thompson, J.D. (2021). Spliceator: Multi-Species Splice Site Prediction Using Convolutional Neural Networks. BMC Bioinform., 22.","DOI":"10.1186\/s12859-021-04471-3"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kyrchanova, O., and Georgiev, P. (2021). Mechanisms of Enhancer-Promoter Interactions in Higher Eukaryotes. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22020671"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41580-022-00474-x","article-title":"Sources, Resolution and Physiological Relevance of R-Loops and RNA\u2013DNA Hybrids","volume":"23","author":"Petermann","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Elsakrmy, N., and Cui, H. (2023). R-Loops and R-Loop-Binding Proteins in Cancer Progression and Drug Resistance. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087064"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Catalanotto, C., Cogoni, C., and Zardo, G. (2016). MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17101712"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kazimierczyk, M., Kasprowicz, M.K., Kasprzyk, M.E., and Wrzesinski, J. (2020). Human Long Noncoding RNA Interactome: Detection, Characterization and Function. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21031027"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"854848","DOI":"10.3389\/fimmu.2022.854848","article-title":"Identification of Biomarkers Associated with CD4+ T-Cell Infiltration with Gene Coexpression Network in Dermatomyositis","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"103255","DOI":"10.1016\/j.jaut.2024.103255","article-title":"Circulating Extracellular Vesicles and Small Non-Coding RNAs Cargo in Idiopathic Inflammatory Myopathies Reveal Differences across Myositis Subsets","volume":"147","author":"Franco","year":"2024","journal-title":"J. Autoimmun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/rheumatology\/keab753","article-title":"Plasma Exosomal RNAs Have Potential as Both Clinical Biomarkers and Therapeutic Targets of Dermatomyositis","volume":"61","author":"Li","year":"2022","journal-title":"Rheumatology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41232-017-0058-1","article-title":"Circulating Plasma MicroRNA Profiling in Patients with Polymyositis\/Dermatomyositis before and after Treatment: MiRNA May Be Associated with Polymyositis\/Dermatomyositis","volume":"38","author":"Hirai","year":"2018","journal-title":"Inflamm. Regen."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Braceras, S., Pinal-Fernandez, I., Casal-Dominguez, M., Pak, K., Milisenda, J.C., Lu, S., Gadina, M., Naz, F., Gutierrez-Cruz, G., and Dell\u2019Orso, S. (2023). Identification of Unique MicroRNA Profiles in Different Types of Idiopathic Inflammatory Myopathy. Cells, 12.","DOI":"10.3390\/cells12172198"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/art.38292","article-title":"Inhibition of Myogenic MicroRNAs 1, 133, and 206 by Inflammatory Cytokines Links Inflammation and Muscle Degeneration in Adult Inflammatory Myopathies","volume":"66","author":"Georgantas","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-018-0732-6","article-title":"Immune-Mediated Necrotizing Myopathy","volume":"20","author":"Mammen","year":"2018","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.3748\/wjg.v17.i35.3994","article-title":"Association of Overexpression of TIF1\u03b3 with Colorectal Carcinogenesis and Advanced Colorectal Adenocarcinoma","volume":"17","author":"Jain","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.27273","article-title":"Reduced Expression of Transcriptional Intermediary Factor 1 Gamma Promotes Metastasis and Indicates Poor Prognosis of Hepatocellular Carcinoma","volume":"60","author":"Ding","year":"2014","journal-title":"Hepatology"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kassem, L., Deygas, M., Fattet, L., Lopez, J., Goulvent, T., Lavergne, E., Chabaud, S., Carrabin, N., Chopin, N., and Bachelot, T. (2015). TIF1\u03b3 Interferes with TGF\u03b21\/SMAD4 Signaling to Promote Poor Outcome in Operable Breast Cancer Patients. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1471-y"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/1756-185X.13424","article-title":"Anti-TIF1\u03b3 Antibody and the Expression of TIF1\u03b3 in Idiopathic Inflammatory Myopathies","volume":"22","author":"Kim","year":"2019","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Harada, Y., Tominaga, M., Iitoh, E., Kaieda, S., Koga, T., Fujimoto, K., Chikasue, T., Obara, H., Kakuma, T., and Ida, H. (2022). Clinical Characteristics of Anti-TIF-1\u03b3 Antibody-Positive Dermatomyositis Associated with Malignancy. J. Clin. Med., 11.","DOI":"10.3390\/jcm11071925"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/ced.13180","article-title":"Expression of the Autoantigen TRIM33\/TIF1\u03b3 in Skin and Muscle of Patients with Dermatomyositis Is Upregulated, Together with Markers of Cellular Stress","volume":"42","author":"Scholtissek","year":"2017","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13075-018-1617-9","article-title":"Genetic Background May Contribute to the Latitude-Dependent Prevalence of Dermatomyositis and Anti-TIF1-\u03b3 Autoantibodies in Adult Patients with Myositis","volume":"20","author":"Parkes","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/art.38863","article-title":"Expression of the Dermatomyositis Autoantigen Transcription Intermediary Factor 1\u03b3 in Regenerating Muscle","volume":"67","author":"Mohassel","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ircmb.2016.04.001","article-title":"Insight into the Role of Long Noncoding RNA in Cancer Development and Progression","volume":"326","author":"Li","year":"2016","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.autrev.2015.05.004","article-title":"Emerging Role of Long Noncoding RNAs in Autoimmune Diseases","volume":"14","author":"Wu","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2927061","DOI":"10.1155\/2019\/2927061","article-title":"Specific Autoantibodies and Clinical Phenotypes Correlate with the Aberrant Expression of Immune-Related MicroRNAs in Dermatomyositis","volume":"2019","author":"Ye","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"154183","DOI":"10.1016\/j.prp.2022.154183","article-title":"Insights on the Potential Oncogenic Impact of Long Non-Coding RNA Nicotinamide Nucleotide Transhydrogenase Antisense RNA 1 in Different Cancer Types; Integrating Pathway(s) and Clinical Outcome(s) Association","volume":"240","author":"Abulsoud","year":"2022","journal-title":"Pathol. Res. Pract."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"990594","DOI":"10.3389\/fgene.2022.990594","article-title":"Comprehensive Analysis of M5C-Related LncRNAs in the Prognosis and Immune Landscape of Hepatocellular Carcinoma","volume":"13","author":"Lu","year":"2022","journal-title":"Front. Genet."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.biopha.2017.03.104","article-title":"Long Non-Coding RNA SNHG1 Regulates Zinc Finger E-Box Binding Homeobox 1 Expression by Interacting with TAp63 and Promotes Cell Metastasis and Invasion in Lung Squamous Cell Carcinoma","volume":"90","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1038\/s41379-020-0563-7","article-title":"A Novel Prognostic Two-Gene Signature for Triple Negative Breast Cancer","volume":"33","author":"Alsaleem","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13046-020-01798-2","article-title":"Noncoding RNAs Regulate Alternative Splicing in Cancer","volume":"40","author":"Liu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"713540","DOI":"10.3389\/fimmu.2021.713540","article-title":"Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease","volume":"12","author":"Ren","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e1631","DOI":"10.1002\/wrna.1631","article-title":"Intron Retention and Its Impact on Gene Expression and Protein Diversity: A Review and a Practical Guide","volume":"12","author":"Grabski","year":"2021","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11926-010-0101-6","article-title":"Dermatomyositis and Type 1 Interferons","volume":"12","author":"Greenberg","year":"2010","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/bs.ircmb.2019.10.002","article-title":"The Versatile Plasmacytoid Dendritic Cell: Function, Heterogeneity, and Plasticity","volume":"349","author":"Leylek","year":"2019","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.dci.2017.08.001","article-title":"Immunomodulation: A Definitive Role of MicroRNA-142","volume":"77","author":"Sharma","year":"2017","journal-title":"Dev. Comp. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/dvdy.24477","article-title":"MicroRNA-142 Is a Multifaceted Regulator in Organogenesis, Homeostasis, and Disease","volume":"246","author":"Shrestha","year":"2017","journal-title":"Dev. Dyn."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/art.41215","article-title":"Muscle Weakness in Myositis: MicroRNA-Mediated Dystrophin Reduction in a Myositis Mouse Model and Human Muscle Biopsies","volume":"72","author":"Kinder","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"727901","DOI":"10.3389\/fphar.2021.727901","article-title":"The Functional Roles of RNAs Cargoes Released by Neutrophil-Derived Exosomes in Dermatomyositis","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.gde.2021.11.007","article-title":"Architecture of RNA\u2013RNA Interactions","volume":"72","author":"Xue","year":"2022","journal-title":"Curr. Opin. Genet. Dev."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/14\/6\/628\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:57:43Z","timestamp":1760108263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/14\/6\/628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":65,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["jpm14060628"],"URL":"https:\/\/doi.org\/10.3390\/jpm14060628","relation":{},"ISSN":["2075-4426"],"issn-type":[{"type":"electronic","value":"2075-4426"}],"subject":[],"published":{"date-parts":[[2024,6,13]]}}}